Literature DB >> 10878394

Long term persistence of herpes simplex virus-specific CD8+ CTL in persons with frequently recurring genital herpes.

C M Posavad1, M L Huang, S Barcy, D M Koelle, L Corey.   

Abstract

Herpes simplex virus (HSV) establishes a lifelong infection in humans. Reactivation of latent virus occurs intermittently so that the immune system is frequently exposed to viral Ag, providing an opportunity to evaluate memory T cells to a persistent human pathogen. We studied the persistence of genital herpes lesion-derived HSV-specific CD8+ CTL from three immunocompetent individuals with frequently recurring genital HSV-2 infection. All CTL clones were HSV-2 type specific and only one to three unique clonotypes were identified from any single biopsy specimen. The TCRBV genes utilized by these clonotypes were sequenced, and clonotype-specific probes were used to longitudinally track these clonotypes in PBMC and genital lesions. CTL clonotypes were consistently detected in PBMC and lesions for at least 2 and up to 7 years, and identical clonotypes infiltrated herpes lesions spaced as long as 7.5 years apart. Moreover, these clones were functionally lytic in vivo over these time periods. Additionally, CTL clones killed target cells infected with autologous viral isolates obtained 6.5 years after CTL clones were established, suggesting that selective pressure by these CTL did not result in the mutation of CTL epitopes. Thus, HSV recurs in the face of persistent CD8+ CTL with no evidence of clonal exhaustion or mutation of CTL epitopes as mechanisms of viral persistence.

Entities:  

Mesh:

Year:  2000        PMID: 10878394     DOI: 10.4049/jimmunol.165.2.1146

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.

Authors:  Malgorzata Gierynska; Uday Kumaraguru; Seong-Kug Eo; Sujin Lee; Arthur Krieg; Barry T Rouse
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

2.  Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells.

Authors:  Michael T Hensel; Tao Peng; Anqi Cheng; Stephen C De Rosa; Anna Wald; Kerry J Laing; Lichen Jing; Lichun Dong; Amalia S Magaret; David M Koelle
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

3.  The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simplex virus type 2 infection.

Authors:  Daniel J J Carr; Todd Wuest; Lisa Tomanek; Robert H Silverman; Bryan R G Williams
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

4.  Bolstering the Number and Function of HSV-1-Specific CD8+ Effector Memory T Cells and Tissue-Resident Memory T Cells in Latently Infected Trigeminal Ganglia Reduces Recurrent Ocular Herpes Infection and Disease.

Authors:  Arif A Khan; Ruchi Srivastava; Aziz A Chentoufi; Elizabeth Kritzer; Sravya Chilukuri; Sumit Garg; David C Yu; Hawa Vahed; Lei Huang; Sabrina A Syed; Julie N Furness; Tien T Tran; Nesburn B Anthony; Christine E McLaren; John Sidney; Alessandro Sette; Randolph J Noelle; Lbachir BenMohamed
Journal:  J Immunol       Date:  2017-05-24       Impact factor: 5.422

5.  Innate immune responses to herpes simplex virus type 2 influence skin homing molecule expression by memory CD4+ lymphocytes.

Authors:  David M Koelle; Jay Huang; Michael T Hensel; Christopher L McClurkan
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 6.  Herpes simplex virus and the chemokines that mediate the inflammation.

Authors:  D J J Carr; L Tomanek
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

7.  Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1.

Authors:  Z Mikloska; L Bosnjak; A L Cunningham
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  Migration of antigen-specific T cells away from CXCR4-binding human immunodeficiency virus type 1 gp120.

Authors:  Diana M Brainard; William G Tharp; Elva Granado; Nicholas Miller; Alicja K Trocha; Xiang-Hui Ren; Brian Conrad; Ernest F Terwilliger; Richard Wyatt; Bruce D Walker; Mark C Poznansky
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Estradiol Enhances Antiviral CD4+ Tissue-Resident Memory T Cell Responses following Mucosal Herpes Simplex Virus 2 Vaccination through an IL-17-Mediated Pathway.

Authors:  Puja Bagri; Ramtin Ghasemi; Joshua J C McGrath; Danya Thayaparan; Emma Yu; Andrew G Brooks; Martin R Stämpfli; Charu Kaushic
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

10.  An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.

Authors:  Mojca Skoberne; Rhonda Cardin; Alexander Lee; Ana Kazimirova; Veronica Zielinski; Danielle Garvie; Amy Lundberg; Shane Larson; Fernando J Bravo; David I Bernstein; Jessica B Flechtner; Deborah Long
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.